Brief: Lineage Cell Therapeutics Appoints Jill Howe As Chief Financial Officer
31/10/2022 12:22
Oct 31 (Reuters) - Lineage Cell Therapeutics Inc
LCTX.A :
* LINEAGE CELL THERAPEUTICS APPOINTS JILL HOWE AS CHIEF
FINANCIAL
OFFICER
* LINEAGE CELL THERAPEUTICS INC SAYS JILL HOWE HAS BEEN
APPOINTED
COMPANY'S CHIEF FINANCIAL OFFICER EFFECTIVE NOVEMBER 14, 2022
Source text for Eikon: ID:nBwbxXFSHa
Further company coverage: LCTX.A
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Lineage Cell Therapeutics
See all newsLineage Cell Therapeutics Q2 revenue falls but posts profit
Brief: Lineage Cell Therapeutics Q2 Income From Operations USD -8.923 Million
Lineage Cell Therapeutics Q1 net loss widens as expenses rise
Lineage Cell Q4 revenue rises on Genentech collaboration
Brief: Lineage Cell Therapeutics FY Income From Operations USD -36.619 Million